Your browser doesn't support javascript.
Smell and Taste Disturbance in COVID-19 Patients: A Prospective Multicenteric Review.
Bhatta, Subash; Sharma, Dibya; Sharma, Santosh; Maharjan, Leison; Bhattachan, Sushma; Shah, Mukesh Kumar; Singhal, Aditya; Ghanpur, Asheesh Dora; Ganesuni, Dushyanth; Saindani, Shraddha Jayant.
  • Bhatta S; Indira Gandhi Memorial Hospital, Male', Maldives.
  • Sharma D; Indira Gandhi Memorial Hospital, Male', Maldives.
  • Sharma S; Devdaha Medical College, Butwal, Nepal.
  • Maharjan L; Patan Academy of Health Sciences, Patan, Nepal.
  • Bhattachan S; Hospital for Advanced Medicine and Surgery, Kathmandu, Nepal.
  • Shah MK; National Medical College, Birgunj, Nepal.
  • Singhal A; Rajshree Medical Research Institute, Bareily, India.
  • Ghanpur AD; Osmania Medical College, Hyderabad, India.
  • Ganesuni D; Continental Hospital and Research Center, Hyderabad, India.
  • Saindani SJ; Deenanath Mangeshkar Hospital and Research Center, Pune, India.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 2): 2978-2984, 2022 Oct.
Article in English | MEDLINE | ID: covidwho-1245751
ABSTRACT
To study the incidence of the smell and taste disturbance in the COVID-19 patients and a follow up at 4 months to observe for the duration of resolution of these symptoms. This is a multicentric prospective study carried out in 3 different countries, from April, 2020 to January, 2021. The COVID-19 positive patients, aged between 15 and 60 years, were inquired about the presence of any smell or taste related symptoms. The same patients were followed up with the telephonic interview after 2 months and then after 4 months, respectively. The duration of resolution of the smell and taste disturbance symptoms was noted. Total of 188 COVID-19 positive patients, average age 33.1 ± 1.7 years, 54.2% males and 45.8% female were included in the study. The smell disturbance was present in 60.6% (hyposmia 36.1%, anosmia 20.2%, and parosmia 4.2%) and taste disturbance in 28.7% of patients (hypogeusia 20.2%, ageusia 6.9%, and parageusia 1.6%). There was improvement of anosmia by 97.4, hyposmia by 95.6%, parosmia by 100%, ageusia by 100%, hypogeusia 94.8%, and parageusia by 66.7%, at 4 months follow up. The present study concludes that the smell and taste disturbances are one of the main early presenting features of the COVID-19 infection. The temporary effect of the COVID-19 infection on the olfactory and gustatory pathway was also highlighted with more than 95% patients improving at 4 months of follow up.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Indian J Otolaryngol Head Neck Surg Year: 2022 Document Type: Article Affiliation country: S12070-021-02664-z

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Indian J Otolaryngol Head Neck Surg Year: 2022 Document Type: Article Affiliation country: S12070-021-02664-z